These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32319079)

  • 1. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
    Tao L; Wang S; Yang L; Jiang L; Li J; Wang X
    Clin Exp Immunol; 2020 Aug; 201(2):161-170. PubMed ID: 32319079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
    Jandus C; Boligan KF; Chijioke O; Liu H; Dahlhaus M; Démoulins T; Schneider C; Wehrli M; Hunger RE; Baerlocher GM; Simon HU; Romero P; Münz C; von Gunten S
    J Clin Invest; 2014 Apr; 124(4):1810-20. PubMed ID: 24569453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma.
    Zhang P; Lu X; Tao K; Shi L; Li W; Wang G; Wu K
    J Surg Res; 2015 Mar; 194(1):107-13. PubMed ID: 25450598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities.
    Shao JY; Yin WW; Zhang QF; Liu Q; Peng ML; Hu HD; Hu P; Ren H; Zhang DZ
    Scand J Immunol; 2016 Sep; 84(3):182-90. PubMed ID: 27312286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells.
    Yoshimura A; Asahina Y; Chang LY; Angata T; Tanaka H; Kitajima K; Sato C
    J Biol Chem; 2021; 296():100477. PubMed ID: 33640457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.
    Zhao D; Jiang X; Xu Y; Yang H; Gao D; Li X; Gao L; Ma C; Liang X
    Front Immunol; 2018; 9():1124. PubMed ID: 29899741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
    Adeniji OS; Kuri-Cervantes L; Yu C; Xu Z; Ho M; Chew GM; Shikuma C; Tomescu C; George AF; Roan NR; Ndhlovu LC; Liu Q; Muthumani K; Weiner DB; Betts MR; Xiao H; Abdel-Mohsen M
    PLoS Pathog; 2021 Nov; 17(11):e1010034. PubMed ID: 34762717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
    Daly J; Carlsten M; O'Dwyer M
    Front Immunol; 2019; 10():1047. PubMed ID: 31143186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Frequency of Dysfunctional Siglec-7
    Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
    Front Immunol; 2021; 12():603133. PubMed ID: 33692781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduced frequency of natural killer cell on siglec-7(+) is associated with progression of hepatitis B virus-related cirrhosis].
    Li YL; Zhang QF; Yin WW; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):420-425. PubMed ID: 30317754
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
    Xiao R; Tian Y; Zhang J; Li N; Qi M; Liu L; Wang J; Li Z; Zhang J; Zhao F; Wang T; Tan S; Li C; Wu Z; Yu M; Jiang X; Zhan P; Gao L; Han B; Liu X; Liang X; Ma C
    J Hepatol; 2024 May; 80(5):792-804. PubMed ID: 38331327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5' promoter CpG sites.
    Huang HT; Su SC; Chiou TJ; Lin YH; Shih YC; Wu YX; Fan TH; Twu YC
    Immunology; 2020 May; 160(1):38-51. PubMed ID: 32027025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
    Ren X; Ji Y; Jiang X; Qi X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells.
    Fong JJ; Tsai CM; Saha S; Nizet V; Varki A; Bui JD
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10410-10415. PubMed ID: 30254166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression.
    Zheng Y; Ma X; Su D; Zhang Y; Yu L; Jiang F; Zhou X; Feng Y; Ma F
    J Immunol Res; 2020; 2020():6243819. PubMed ID: 32322597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
    Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
    Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.